The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
11-methyl-6-(naphthalen-1-yl)indolizino[3,2-c]quinoline ID: ALA5205879
PubChem CID: 126483447
Max Phase: Preclinical
Molecular Formula: C26H18N2
Molecular Weight: 358.44
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cccn2c1cc1c3ccccc3nc(-c3cccc4ccccc34)c12
Standard InChI: InChI=1S/C26H18N2/c1-17-8-7-15-28-24(17)16-22-20-12-4-5-14-23(20)27-25(26(22)28)21-13-6-10-18-9-2-3-11-19(18)21/h2-16H,1H3
Standard InChI Key: KVCOXSJEVVMBAS-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 33 0 0 0 0 0 0 0 0999 V2000
-2.5774 1.7284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8628 2.1407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1510 1.7289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1510 0.9036 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.8611 0.4919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5774 0.8999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3663 0.6487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1187 1.3162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3662 1.9838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9367 1.2296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2726 0.4758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7914 -0.1893 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0290 -0.1081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4416 -0.8228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0968 0.3896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5774 1.0599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2416 1.8092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4206 1.8950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8628 2.9654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0293 -1.5376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4413 -2.2496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2667 -2.2496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6786 -1.5393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2704 -0.8228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7908 -1.5388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2018 -2.2517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7934 -2.9611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0286 -2.9654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 1 0
5 4 1 0
6 5 2 0
1 6 1 0
4 7 1 0
8 7 2 0
9 8 1 0
3 9 2 0
8 10 1 0
11 10 2 0
12 11 1 0
13 12 2 0
7 13 1 0
14 13 1 0
11 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
10 18 1 0
2 19 1 0
20 14 2 0
21 20 1 0
22 21 2 0
23 22 1 0
24 23 2 0
14 24 1 0
20 25 1 0
26 25 2 0
27 26 1 0
28 27 2 0
21 28 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 358.44Molecular Weight (Monoisotopic): 358.1470AlogP: 6.77#Rotatable Bonds: 1Polar Surface Area: 17.30Molecular Species: NEUTRALHBA: 2HBD: ┄#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 1.99CX LogP: 6.32CX LogD: 6.32Aromatic Rings: 6Heavy Atoms: 28QED Weighted: 0.32Np Likeness Score: -0.58
References 1. Kim K, Lee JH, Kim S, Lee S, Lee D, Kim HY, Kim I, Kim Y.. (2021) Anti-amyloidogenic indolizino[3,2-c ]quinolines as imaging probes differentiating dense-core, diffuse, and coronal plaques of amyloid-β., 12 (11.0): [PMID:34825188 ] [10.1039/D1MD00030F ]